Advertisement
Home Tags Hepatitis

Tag: Hepatitis

Testing for hepatitis C virus core antigen could be a good alternative for nucleic acid testing for diagnosis of chronic hepatitis C virus

Hep C Core Antigen Assays Show High Sensitivity, Specificity

0
Certain HCV core antigen assays could replace confirmatory nucleic acid testing for diagnosis of HCV
Use of tenofovir disoproxil fumarate during pregnancy can reduce the rate of mother-to-child transmission of hepatitis B virus

Tenofovir Disoproxil Fumarate Can Cut HBV Transmission

0
Use of TDF in pregnancy is associated with a reduced rate of mother-to-child transmission
For patients with compensated hepatitis C virus cirrhosis

Survival for HCV Cirrhosis, SVR Same As General Population

0
Findings in patients with compensated HCV cirrhosis who achieve SVR on interferon-based regimen
The number of hepatitis C-linked deaths in the United States reached a record high in 2014

CDC: Hepatitis C Leads Infectious Disease Mortality in U.S.

0
CDC notes that nearly 20,000 Americans died in 2014 from hepatitis C infection
The addition of antiviral therapy to sorafenib is a cost-effective option compared with sorafenib monotherapy in patients with advanced hepatitis B virus-related hepatocellular carcinoma in China

Adding Antiviral to Sorafenib Is Cost-Effective in HCC

0
More cost-effective than sorafenib monotherapy for HBV-related cancer
Low-cost generic antiviral drugs are as effective and safe as more expensive brand-name drugs in treating people with hepatitis C

Generic Antivirals Equally Effective to Brand Rx in Hep C

0
Inexpensive antivirals could be a game-changer in many countries, researchers say
Hepatitis C may increase the risk for certain types of head and neck cancers

Hepatitis C Found to Up Odds for Certain Head and Neck Cancers

0
Researcher sees need for improved screening, treatment
Hepatitis C virus (HCV)-infected livers seem to do as well as healthy livers in patients with HCV

HCV-Infected Liver Transplants Can Work for HCV+ Patients

0
Findings might help reduce organ waiting list, researchers say
The burden of hepatitis C virus and associated disease is projected to remain considerable even in the era of oral direct-acting antivirals

Burden of Hep C Virus Substantial Despite Oral Antiviral Therapy

0
In the next 35 years, 320,000 patients expected to die, 157,000 to develop hepatocellular carcinoma
The total medical costs associated with interferon-based antiviral treatment among patients with chronic hepatitis C virus infection average €14

Total Medical Costs of $16K for IFN-Based Antiviral Tx for HCV

0
Mean cost per sustained virologic response €38,514; cost increases with more advanced liver disease